Culture Biosciences, a company involved in upstream bioprocess development and Cytiva, a company that advances and accelerates the development of therapeutics, entered into a collaboration to advance innovation in upstream bioprocessing by providing customers greater access to predictive and robust scale-up capabilities. Cytiva and Culture Biosciences aim to bring to customers new bioprocess solutions that use digitization, in-silico approaches, and virtual monitoring and control of experiments....